학술논문
SPIOMET4HEALTH—efficacy, tolerability and safety of lifestyle intervention plus a fixed dose combination of spironolactone, pioglitazone and metformin (SPIOMET) for adolescent girls and young women with polycystic ovary syndrome: study protocol for a multicentre, randomised, double-blind, placebo-controlled, four-arm, parallel-group, phase II clinical trial
Document Type
Article
Author
Garcia-Beltran, C.; Malpique, R.; Díaz, M.; Marin, S.; Salvador, C.; Ibáñez, L.; Andersen, M.S.; Glintborg, D.; Ravn, P.; Bas, F.; Darendeliler, F.; Yildiz, M.; Bassols, J.; Dieris, B.; Reinehr, T.; Singer, V.; Fanelli, F.; Gambineri, A.; Fröhlich-Reiterer, E.; López-Bermejo, A.; Mann, C.; Obermayer-Pietsch, B.; Ødegård, R.; Vanky, E.; Renzulli, M.; Torres, J.V.; de Zegher, F.
Source
In: Trials . (Trials, December 2023, 24(1))
Subject
Language
English
ISSN
17456215